Harbin Honor Pharmaceutical Co., Ltd. Stock Code: 002437 Stock Abbreviation: Honor Pharmaceutical Announcement Number: 2026-030 As an independent director of Harbin Honor Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), I have strictly followed the Company Law, Securities Law, Administrative Measures for Independent Directors of Listed Companies, Shenzhen Stock Exchange Stock Listing Rules, Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guide No. 1 - Norms for Operations of Main Board Listed Companies, and other relevant laws, regulations, and the Articles of Association. I have diligently performed my duties, actively attended relevant meetings, carefully reviewed all proposals submitted to the board of directors, expressed independent opinions on relevant company matters, and effectively fulfilled my role as an independent director. The following is a summary of my performance of independent director duties during my term of office in 2025:
I. Basic Information of Independent Director
(I) Personal Work Experience, Professional Background, and Concurrent Positions I am Zhang Xiaodan, born in September 1975, a Chinese national with a bachelor's degree. I previously worked as a staff member at the State Administration for Market Regulation, a trust manager at CITIC Trust Co., Ltd., and the Deputy General Manager and General Manager of Phoenix Healthcare Group. I served as an independent director of the Company from December 20, 2022, to February 6, 2025.
(II) Statement on Circumstances Affecting Independence As an independent director of the Company, I meet the independence requirements stipulated in the Administrative Measures for Independent Directors of Listed Companies and have no circumstances that affect my independence.
II. Overview of Independent Director's Annual Performance